Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Barrett Esophagus 1

Interventions

Endoscopy, Digestive System 5Aspirin 3YF 476 2Narrow Band Imaging 2Esomeprazole 2Dexlansoprazole 2Biopsy 2omeprazole, sodium bicarbonate drug combination 1chlorhexidine gluconate 1Ursodeoxycholic Acid 1Tomography, Optical Coherence 1Sunitinib 1Specimen Handling 1Radiofrequency Ablation 1Proton Pump Inhibitors 1Photochemotherapy 1Omeprazole 1Metformin 1Genes, BRCA1 1Endoscopy 1Endoscopic Mucosal Resection 1Endoscopes 1Docosahexaenoic Acids 1Dihematoporphyrin Ether 1Diagnostic Imaging 1Cryosurgery 1Contraceptive Devices, Female 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Barrett Esophagus × Ursodeoxycholic Acid × Clear all
NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡